1. Home
  2. DSWL vs GANX Comparison

DSWL vs GANX Comparison

Compare DSWL & GANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DSWL
  • GANX
  • Stock Information
  • Founded
  • DSWL 1987
  • GANX 2017
  • Country
  • DSWL Macau
  • GANX United States
  • Employees
  • DSWL N/A
  • GANX N/A
  • Industry
  • DSWL Plastic Products
  • GANX Biotechnology: Pharmaceutical Preparations
  • Sector
  • DSWL Industrials
  • GANX Health Care
  • Exchange
  • DSWL Nasdaq
  • GANX Nasdaq
  • Market Cap
  • DSWL 42.5M
  • GANX 41.9M
  • IPO Year
  • DSWL 1995
  • GANX 2021
  • Fundamental
  • Price
  • DSWL $2.37
  • GANX $2.27
  • Analyst Decision
  • DSWL
  • GANX Strong Buy
  • Analyst Count
  • DSWL 0
  • GANX 5
  • Target Price
  • DSWL N/A
  • GANX $7.60
  • AVG Volume (30 Days)
  • DSWL 16.8K
  • GANX 218.6K
  • Earning Date
  • DSWL 11-15-2024
  • GANX 03-25-2025
  • Dividend Yield
  • DSWL 8.44%
  • GANX N/A
  • EPS Growth
  • DSWL 69.42
  • GANX N/A
  • EPS
  • DSWL 0.65
  • GANX N/A
  • Revenue
  • DSWL $66,813,999.00
  • GANX N/A
  • Revenue This Year
  • DSWL N/A
  • GANX N/A
  • Revenue Next Year
  • DSWL N/A
  • GANX N/A
  • P/E Ratio
  • DSWL $3.65
  • GANX N/A
  • Revenue Growth
  • DSWL N/A
  • GANX N/A
  • 52 Week Low
  • DSWL $2.14
  • GANX $0.89
  • 52 Week High
  • DSWL $2.74
  • GANX $5.19
  • Technical
  • Relative Strength Index (RSI)
  • DSWL 48.65
  • GANX 47.71
  • Support Level
  • DSWL $2.31
  • GANX $2.30
  • Resistance Level
  • DSWL $2.40
  • GANX $2.81
  • Average True Range (ATR)
  • DSWL 0.07
  • GANX 0.25
  • MACD
  • DSWL 0.01
  • GANX -0.03
  • Stochastic Oscillator
  • DSWL 73.33
  • GANX 35.33

About DSWL Deswell Industries Inc.

Deswell Industries Inc is engaged in the manufacturing and selling of injection-molded plastic parts and components. In addition, it also offers manufacturing services for electronic products and subassemblies and manufactures metallic molds and accessory parts for original equipment manufacturers and contract manufacturers. The company conducts all of its manufacturing activities at separate plastics, electronics and metallic operation factories located in the People's Republic of China. It operates through the Plastic Injection Molding and Electronic Products Assembling segments. The firm offers products such as automobile components, medical testing equipment, parts for audio equipment, av receivers, active subwoofers, digital system key sets, communication products and others.

About GANX Gain Therapeutics Inc.

Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across, several therapeutics areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders, and oncology. The company's clinical-stage product candidate, GT-02287, is being developed for the treatment of GBA1 Parkinson's disease. The company uses its computational target and drug discovery platform, Magellan, to discover novel allosteric binding sites on proteins implicated in disease and to identify proprietary small molecules that bind these sites to modulate protein function and treat the underlying cause of the disease. The company derives revenues from collaboration and licensing agreements.

Share on Social Networks: